NYSE: EVMNEvommune Inc Stock Ownership - Who owns Evommune?
Insider buying vs selling
Have Evommune Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Kyle Carver | Chief Financial Officer | 2026-07-08 | 1,000 | $13.26 | $13.26kBuy |
| Arthur S. Kirsch | Director | 2026-07-07 | 10,000 | $13.30 | $133.00kBuy |
| Luis C. Pena | President CEO | 2026-06-22 | 7,438 | $22.71 | $168.92kSell |
| Jeegar Pravinkumar Patel | Chief Scientific Officer | 2026-06-22 | 1,488 | $3.84 | $5.71kBuy |
| Jeegar Pravinkumar Patel | Chief Scientific Officer | 2026-06-22 | 1,488 | $22.50 | $33.48kSell |
| Janice Suzann Drew | Chief of Dev. Operations | 2026-06-22 | 3,839 | $3.84 | $14.74kBuy |
| Janice Suzann Drew | Chief of Dev. Operations | 2026-06-22 | 16,161 | $2.99 | $48.32kBuy |
| Janice Suzann Drew | Chief of Dev. Operations | 2026-06-22 | 20,000 | $22.63 | $452.60kSell |
| David E. 1. Cohen | Director | 2026-06-02 | 600 | $21.38 | $12.83kSell |
| David E. 1. Cohen | Director | 2026-06-02 | 5,456 | $20.21 | $110.27kSell |
EVMN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when EVMN insiders and whales buy or sell their stock.
EVMN Shareholders
What type of owners hold Evommune Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| 7. Cooperative Ua Lsp | 28.15% | 10,217,946 | $144.28M | Insider |
| Weegen Felice Isabel Verduynvan | 14.57% | 5,288,313 | $74.67M | Insider |
| Eqt Fund Management Sa Rl | 13.58% | 4,929,633 | $69.61M | Institution |
| Ra Capital Management LP | 9.63% | 3,494,638 | $49.34M | Institution |
| Robert Lorne Hopfner | 9.29% | 3,372,001 | $47.61M | Insider |
| Pivotal Bioventure Partners Investment Advisor LLC | 5.31% | 1,926,943 | $27.21M | Institution |
| Andera Partners | 5.23% | 1,897,362 | $26.79M | Institution |
| Rtw Investments LP | 4.14% | 1,502,235 | $21.21M | Institution |
| Jpmorgan Chase Co | 4.02% | 1,459,420 | $20.61M | Institution |
| Mpm Bioimpact LLC | 4.01% | 1,455,863 | $20.56M | Institution |
EVMN vs Biotech Stocks
Evommune Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.